135 related articles for article (PubMed ID: 8370555)
1. [Effects of terguride, an ergot alkaloid derivative, on the central nervous system: biochemical and behavioral studies].
Ikoma Y; Akai T; Nakata Y; Hara K; Wachtel H; Yamaguchi M
Nihon Yakurigaku Zasshi; 1993 Aug; 102(2):113-29. PubMed ID: 8370555
[TBL] [Abstract][Full Text] [Related]
2. Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
Svensson K; Ekman A; Piercey MF; Hoffmann WE; Lum JT; Carlsson A
Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):263-74. PubMed ID: 1683686
[TBL] [Abstract][Full Text] [Related]
3. Terguride as a new anti-hyperprolactinemic agent: characterization in rats and dogs in comparison with bromocriptine.
Mizokawa T; Akai T; Nakada Y; Yamaguchi M; Nakagawa H; Hasan S; Rettig KJ; Wachtel H
Jpn J Pharmacol; 1993 Nov; 63(3):269-78. PubMed ID: 7906316
[TBL] [Abstract][Full Text] [Related]
4. Terguride, a mixed dopamine agonist-antagonist, in animal models of Parkinson's disease.
Koller WC; Herbster G
Neurology; 1987 Apr; 37(4):723-7. PubMed ID: 3561789
[TBL] [Abstract][Full Text] [Related]
5. Central antidopaminergic properties of 2-bromolisuride, an analogue of the ergot dopamine agonist lisuride.
Wachtel H; Kehr W; Sauer G
Life Sci; 1983 Dec; 33(26):2583-97. PubMed ID: 6607392
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of 2-bromoterguride at human dopamine D2, porcine serotonin 5-hydroxytryptamine 2A, and α2C-adrenergic receptors, and its antipsychotic-like effects in rats.
Jantschak F; Brosda J; Franke RT; Fink H; Möller D; Hübner H; Gmeiner P; Pertz HH
J Pharmacol Exp Ther; 2013 Oct; 347(1):57-68. PubMed ID: 23863695
[TBL] [Abstract][Full Text] [Related]
7. The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats.
McDougall SA; Hernandez RM; Reichel CM; Farley CM
Psychopharmacology (Berl); 2005 Apr; 178(4):431-9. PubMed ID: 15765258
[TBL] [Abstract][Full Text] [Related]
8. Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys.
Akai T; Yamaguchi M; Mizuta E; Kuno S
Ann Neurol; 1993 May; 33(5):507-11. PubMed ID: 8098931
[TBL] [Abstract][Full Text] [Related]
9. Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
Clark D; Furmidge LJ; Petry N; Tong ZY; Ericsson M; Johnson D
Psychopharmacology (Berl); 1991; 105(3):381-92. PubMed ID: 1686815
[TBL] [Abstract][Full Text] [Related]
10. Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys.
Platt DM; Rodefer JS; Rowlett JK; Spealman RD
Psychopharmacology (Berl); 2003 Mar; 166(3):298-305. PubMed ID: 12589523
[TBL] [Abstract][Full Text] [Related]
11. Effects of a partial dopamine D2-like agonist on the cocaine-induced behavioral sensitization of preweanling rats.
Sibole JM; Matea PJ; Krall CM; McDougall SA
Pharmacol Biochem Behav; 2003 Aug; 76(1):27-34. PubMed ID: 13679214
[TBL] [Abstract][Full Text] [Related]
12. Anorectic effect of lisuride and other ergot derivatives in the rat.
Carruba MO; Ricciardi S; Müller EE; Mantegazza P
Eur J Pharmacol; 1980 Jun; 64(2-3):133-41. PubMed ID: 6105081
[TBL] [Abstract][Full Text] [Related]
13. The partial dopamine D2-like receptor agonist terguride functions as an agonist in preweanling rats after a 5-day reserpine regimen.
Wacan JJ; Reichel CM; Farley CM; McDougall SA
Psychopharmacology (Berl); 2006 Mar; 185(1):104-11. PubMed ID: 16447063
[TBL] [Abstract][Full Text] [Related]
14. Dual action on central dopamine function of transdihydrolisuride, a 9, 10-dihydrogenated analogue of the ergot dopamine agonist lisuride.
Wachtel H; Dorow R
Life Sci; 1983 Jan; 32(4):421-32. PubMed ID: 6827903
[No Abstract] [Full Text] [Related]
15. 2-Bromolisuride, an ergot derivative, with dopamine antagonistic and serotonin agonistic properties.
Fink H; Morgenstern R; Ott T
Pharmacol Biochem Behav; 1991 Feb; 38(2):321-5. PubMed ID: 1905409
[TBL] [Abstract][Full Text] [Related]
16. [Effects of an ergot derivative, lisuride, on the central dopaminergic system -- studies of behavioral pharmacology].
Hara K; Ikoma Y; Oshino N
Nihon Yakurigaku Zasshi; 1982 Jul; 80(1):1-13. PubMed ID: 7173731
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of lisuride and terguride, ergot alkaloid derivatives, on the field-stimulated vas deferens of mouse.
Carratù MR; DeSerio A; Mitolo-Chieppa D; Federico F
J Neural Transm Gen Sect; 1991; 84(3):221-32. PubMed ID: 1883597
[TBL] [Abstract][Full Text] [Related]
18. Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions.
Fink H; Morgenstern R
Psychopharmacology (Berl); 1985; 85(4):464-8. PubMed ID: 2991961
[TBL] [Abstract][Full Text] [Related]
19. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
[TBL] [Abstract][Full Text] [Related]
20. [Effects of the partial dopamine receptor agonist, terguride, on the field-stimulated vas deferens in the mouse].
Carratù MR; De Serio A; Lagioia R; Conte-Camerino D; Ferrari E; Mitolo-Chieppa D
Boll Soc Ital Biol Sper; 1990 Jan; 66(1):35-42. PubMed ID: 1969741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
